Morris, Laurel S.
Kundu, Prantik
Costi, Sara
Collins, Abigail
Schneider, Molly
Verma, Gaurav
Balchandani, Priti
Murrough, James W.
Article History
Received: 21 December 2018
Accepted: 10 January 2019
First Online: 15 February 2019
Conflict of interest
: In the past 5 years, Dr. Murrough has provided consultation services to Boehreinger Ingelheim, Sage Therapeutics, Novartis, Allergan, Fortress Biotech, Janssen Research and Development, Medavante-Prophase, and Global Medical Education (GME) and has received research support from Avanir Pharmaceuticals, Inc. Dr. Murrough is named on a patent pending for neuropeptide Y as a treatment for mood and anxiety disorders. Dr. Balchandani is a named inventor on patents relating to MRI and radiofrequency pulse design. The patents have been licensed to GE Healthcare, Siemens AG, and Philips international. Dr. Balchandani receives royalty payments relating to these patents.